Etanercept (Enbrel®), infliximab (Remicade®), and adalimumab (Humira®) are TNF inhibitors that are used in animal disease models of MS [33] and have been approved for treatment of patients with rheumatoid arthritis, inflammatory bowel disease, and psoriasis [34]. This evidence concerns the gene TNF and psoriasis.